{Reference Type}: Journal Article
{Title}: Role of non-coding RNAs mediated pyroptosis on cancer therapy: a review.
{Author}: Zhao D;Wu T;Tan Z;Xu J;Lu Z;
{Journal}: Expert Rev Anticancer Ther
{Volume}: 24
{Issue}: 5
{Year}: 2024 May 12
{Factor}: 3.627
{DOI}: 10.1080/14737140.2024.2341737
{Abstract}: <B>UNASSIGNED: </B>Non-coding RNAs (ncRNAs), which are incapable of encoding proteins, are involved in the progression of numerous tumors by altering transcriptional and post-transcriptional processing. Recent studies have revealed prominent features of ncRNAs in pyroptosis, a type of non-apoptotic programmed cellular destruction linked to an inflammatory reaction. Drug resistance has arisen gradually as a result of anti-apoptotic proteins, therefore strategies based on pyroptotic cell death have attracted increasing attention. We have observed that ncRNAs may exert significant influence on cancer therapy, chemotherapy, radio- therapy, targeted therapy and immunotherapy, by regulating pyroptosis.<BR><B>UNASSIGNED: </B>Literatures were searched (December 2023) for studies on cancer therapy for ncRNAs-mediated pyroptotic cell death.<BR><B>UNASSIGNED: </B>The most universal mechanical strategy for ncRNAs to regulate target genes is competitive endogenous RNAs (ceRNA). Besides, certain ncRNAs could directly interact with proteins and modulate downstream genes to induce pyroptosis, resulting in tumor growth or inhibition. In this review, we aim to display that ncRNAs, predominantly long non-coding RNAs (lncRNAs), microRNAs (miRNAs) and circular RNAs (circRNAs), could function as potential biomarkers for diagnosis and prognosis and produce new insights into anti-cancer strategies modulated by pyroptosis for clinical applications.